These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5319375)

  • 1. [Effect of a combination of librium and a spasmolytic agent on stomach secretion].
    Hoffmann G; Wetzel HP
    Med Welt; 1965 Jul; 31():1743-7. PubMed ID: 5319375
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind study of a psychotropic-anticholinergic drug in gastric disorders.
    Cromwell HA
    Med Times; 1968 Sep; 96(9):933-8. PubMed ID: 4876840
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic trial with a new anti-gastrin agent combined with a spasmolytic].
    Malafaia O
    Rev Bras Med; 1972 Mar; 29(3):148-50. PubMed ID: 5033158
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic trial of an antispasmodic and anxiolytic medicamentous combination].
    Vallon C; Revillard JP; Bel A; Girard M
    J Med Lyon; 1965 Sep; 46(82):1355-66. PubMed ID: 5898062
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical use of prifinium bromide: a new spasmolytic agent].
    Marini U; Spotti D; Visconti P
    Clin Ter; 1978 Nov; 87(4):367-74. PubMed ID: 36254
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of a new gastroenterotrophic, spasmolytic and antacid combination (Gefarmil compositum)].
    Rovera R; Furlotti MG
    Minerva Gastroenterol; 1970; 16(4):191-8. PubMed ID: 4930898
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trials of a combination of an original gastric demulcent and a synthetic anticholinergic agent].
    Evreux M; Jenoudet L
    Lyon Med; 1972 Jun; 227(11):1181-4. PubMed ID: 4564809
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experimentation in gastro-duodenal pathology with an anticholinergic, oxypyrronium bromide. Objective evaluation of its action on gastric secretion].
    Dureux JB; Rauber G; Regnier F; Ruff G
    Ann Med Nancy; 1965; 4():633-41. PubMed ID: 5839672
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effects of a new antispastic and anxiolytic preparation on various diseases of the digestive tract].
    Surrenti C
    Clin Ter; 1970 May; 53(3):235-46. PubMed ID: 5456481
    [No Abstract]   [Full Text] [Related]  

  • 10. [DA 3177 a new synthetic spasmolytic agent in the management of spastic-dyskinetic conditions of the digestive tract. Double-blind controlled clinical trial].
    Bonzi G; Reguzzoni G; Rocca F; Negri L
    Clin Ter; 1979 Apr; 89(2):187-96. PubMed ID: 385213
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value of a new combined antispasmodic-antalgic in current medical practice].
    Galley P
    Therapeutique; 1969 Dec; 45(10):1021-4. PubMed ID: 5396160
    [No Abstract]   [Full Text] [Related]  

  • 12. Antisecretory effects of Librax in patients with duodenal ulcer.
    Head HB; Hammond JB
    Am J Dig Dis; 1968 Jun; 13(6):540-50. PubMed ID: 4879036
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experimentation with pentanobornamide, a new synthetic spasmolytic].
    Miracco A; Peluso C
    Clin Ter; 1970 Mar; 52(6):557-63. PubMed ID: 4916457
    [No Abstract]   [Full Text] [Related]  

  • 14. [Controlled clinical research on ketoscilium, a new parasympatholytic].
    Chiarioni T; Mancini L
    Clin Ter; 1969 Feb; 48(4):319-40. PubMed ID: 5355891
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of central M cholinolytics on the negative aspects of intubation].
    Barnaulov OD
    Ter Arkh; 1970 Mar; 42(3):40-2. PubMed ID: 5453865
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled evaluation of a new synthetic spasmolytic (DA 3177) in/pathology of the digestive system].
    Battocchio F; Negri L; Tacchettti G
    Clin Ter; 1979 Jun; 89(6):601-10. PubMed ID: 397029
    [No Abstract]   [Full Text] [Related]  

  • 17. The evaluation of Bellergal Tablets compared to librium and placebo in the treatment of symptoms of anxiety tension states associated with functional gastrointestinal disorders.
    Samet CM
    Psychosomatics; 1976; 17(4):202-9. PubMed ID: 794908
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of a new spasmolytic agent in digestive disorders].
    Dupérié MJ
    Bord Med; 1972 Sep; 5(13):1611-2. PubMed ID: 4636182
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of a new digestivo-spasmolytic agent].
    Glassman J; Odzak A
    Prensa Med Argent; 1966 Sep; 53(37):2033-5. PubMed ID: 5993479
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of anticholinergic agents on human gastric secretion. Experiment with balanced incomplete block].
    Bonollo L; Mainardi M; Tenconi LT; Nicolis FB
    Boll Chim Farm; 1971 Sep; 110(9):536-44. PubMed ID: 4944882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.